AlphaCrest Capital Management’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,763	Closed	-$279K	–	298
2022 Q3	$279K	Buy	+5,763	New	+$279K	0.02%	1164
2021 Q3	–	Sell	-19,909	Closed	-$394K	–	1263
2021 Q2	$394K	Buy	+19,909	New	+$394K	0.02%	1031